1,355 followers
Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with… https://t.co/JvtKFLZqGn
Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with… https://t.co/JvtKFLZqGn
Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with mucop... http://t.co/FPmgKZjfFW
Immunogenicity of idursulfase, clinical outcomes in very young patients (16m-7.5y) with #HunterSyndrome http://t.co/RkWSVURsvk #mpsarticle